Natural Capsules Limited
BSE: NATCAPSUQ
Prev Close
212.95
Open Price
214.75
Volume
2,207
Today Low / High
204.7 / 215.75
52 WK Low / High
163.55 / 299
Range
196 - 217
The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 206.5, reflecting a change of -6.45 (-3.02888%). The expected target range on the BSE is 196 - 217. The stock is showing a downward trend on the BSE. This could indicate a potential risk for investors who are considering buying at this moment.
Natural Capsules Limited Graph
Natural Capsules Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Natural Capsules Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 206.50, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 206.50 | 208.57 | 187.71 - 229.42 |
| 210.63 | 168.50 - 252.76 | ||
| 212.70 | 148.89 - 276.50 | ||
| Bearish Scenario | 206.50 | 204.44 | 183.99 - 224.88 |
| 202.37 | 161.90 - 242.84 | ||
| 200.31 | 140.21 - 260.40 |
Overview of Natural Capsules Limited
ISIN
INE936B01015
Industry
Medical - Pharmaceuticals
Vol.Avg
2,746
Market Cap
2,202,158,540
Last Dividend
0
Official Website
IPO Date
DCF Diff
N/A
DCF
0
Financial Ratios Every Investor Needs
Stock Dividend of NATCAPSUQ
| Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|---|
| 2023-07-20 | July 20, 23 | 1 | 1 | 2023-07-20 | 2023-08-27 | |
| 2022-09-09 | September 09, 22 | 1 | 1 | 2022-09-12 | 2022-10-20 | |
| 2021-07-06 | July 06, 21 | 0.81999 | 0.81999 | 2021-07-07 | 2021-08-14 | |
| 2020-08-12 | August 12, 20 | 0.492 | 0.492 | 2020-08-13 | 2020-09-20 | |
| 2019-08-13 | August 13, 19 | 0.81999 | 0.81999 | 2019-08-14 | 2019-09-21 |
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 169.21 Cr | 108.15 Cr | 61.05 Cr | 0.3608 | 0.00 Cr | 0.00 Cr | 8.40 Cr | 0.62 Cr | 0.58 | 18.22 Cr | 0.0036 |
| 2024-03-31 | 155.42 Cr | 99.71 Cr | 55.71 Cr | 0.3584 | 2.08 Cr | 2.05 Cr | 11.24 Cr | 5.55 Cr | 6.23 | 21.99 Cr | 0.0357 |
| 2023-03-31 | 172.37 Cr | 78.68 Cr | 93.69 Cr | 0.5435 | 2.39 Cr | 1.66 Cr | 27.24 Cr | 18.45 Cr | 19.89 | 35.93 Cr | 0.1070 |
| 2022-03-31 | 135.07 Cr | 59.80 Cr | 75.26 Cr | 0.5572 | 2.12 Cr | 1.85 Cr | 20.28 Cr | 13.91 Cr | 19.84 | 26.51 Cr | 0.1030 |
| 2021-03-31 | 79.51 Cr | 37.43 Cr | 42.09 Cr | 0.5293 | 0.98 Cr | 1.06 Cr | 7.18 Cr | 6.91 Cr | 9.09 | 14.01 Cr | 0.0869 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 5.28 Cr | 419.35 Cr | 162.19 Cr | 232.9361 Cr | 105.19 Cr | 99.91 Cr | 25.46 Cr | 283.63 Cr | 0.00 Cr | 0.00 Cr | 6.09 Cr | 99.9928 Cr |
| 2024-03-31 | 1.95 Cr | 376.53 Cr | 147.72 Cr | 203.8001 Cr | 109.01 Cr | 107.06 Cr | 23.20 Cr | 246.10 Cr | 0.00 Cr | 0.00 Cr | -4.92 Cr | 76.4739 Cr |
| 2023-03-31 | 1.27 Cr | 288.76 Cr | 140.52 Cr | 123.2261 Cr | 96.79 Cr | 95.52 Cr | 8.85 Cr | 183.36 Cr | 12.53 Cr | 0.15 Cr | 0.60 Cr | 66.9419 Cr |
| 2022-03-31 | 1.40 Cr | 164.28 Cr | 81.30 Cr | 82.9793 Cr | 52.78 Cr | 51.38 Cr | 4.58 Cr | 84.85 Cr | 10.31 Cr | 0.08 Cr | 0.52 Cr | 44.7680 Cr |
| 2021-03-31 | 0.10 Cr | 97.04 Cr | 34.94 Cr | 62.0954 Cr | 10.29 Cr | 10.19 Cr | 6.61 Cr | 45.08 Cr | 6.01 Cr | 0.12 Cr | 0.79 Cr | 33.3921 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 14.0945 Cr | -44.6302 Cr | 22.4799 Cr | -30.5357 Cr | 0.0000 Cr | 5.2842 Cr | -44.6302 Cr | 0.6174 Cr | -5.1888 Cr | 0.0000 Cr | -6.4215 Cr |
| 2024-03-31 | -8.3538 Cr | -72.5861 Cr | 81.7169 Cr | -79.9822 Cr | 0.7771 Cr | 2.2548 Cr | -71.6284 Cr | 5.5535 Cr | 12.4613 Cr | -0.9298 Cr | -10.1868 Cr |
| 2023-03-31 | 17.2167 Cr | -104.6295 Cr | 87.4920 Cr | -88.6743 Cr | 0.0792 Cr | 1.4777 Cr | -105.8910 Cr | 24.9927 Cr | 44.2684 Cr | -0.7720 Cr | -4.2708 Cr |
| 2022-03-31 | -0.5218 Cr | -45.8750 Cr | 47.6977 Cr | -46.6021 Cr | 1.3009 Cr | 1.3985 Cr | -46.0803 Cr | 19.3865 Cr | 42.6356 Cr | -0.6233 Cr | 2.0316 Cr |
| 2021-03-31 | 5.7885 Cr | -8.5385 Cr | 2.5194 Cr | -10.6330 Cr | -0.2306 Cr | 0.0976 Cr | -16.4215 Cr | 9.1902 Cr | 3.3667 Cr | -0.3740 Cr | -1.3291 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 44.97 Cr | 28.67 Cr | 16.30 Cr | 0.3624 | 2.23 Cr | 0.52 Cr | 0.49 | 4.69 Cr | 0.0116 |
| 2024-12-31 | 43.83 Cr | 22.29 Cr | 21.54 Cr | 0.4915 | 1.93 Cr | 0.11 Cr | 0.10 | 4.38 Cr | 0.0024 |
| 2024-09-30 | 41.22 Cr | 19.83 Cr | 21.40 Cr | 0.5190 | 2.16 Cr | -0.61 Cr | -0.60 | 4.61 Cr | -0.0149 |
| 2024-06-30 | 39.18 Cr | 25.57 Cr | 13.61 Cr | 0.3474 | 2.08 Cr | 0.60 Cr | 0.64 | 4.54 Cr | 0.0153 |
| 2024-03-31 | 40.22 Cr | 26.46 Cr | 13.76 Cr | 0.3421 | 1.91 Cr | 0.96 Cr | 1.31 | 5.03 Cr | 0.0240 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 5.28 Cr | 0.00 Cr | 5.28 Cr | 62.24 Cr | 25.46 Cr | 129.59 Cr | 283.63 Cr | 419.35 Cr | 162.19 Cr |
| 2024-12-31 | 0.00 Cr | 0.00 Cr | 14.06 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -258.33 Cr |
| 2024-09-30 | 9.45 Cr | 4.61 Cr | 14.06 Cr | 0.00 Cr | 22.09 Cr | 134.94 Cr | 263.55 Cr | 404.66 Cr | 146.32 Cr |
| 2024-06-30 | 0.00 Cr | 0.00 Cr | 13.26 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -228.80 Cr |
| 2024-03-31 | 13.34 Cr | 11.01 Cr | 13.34 Cr | 54.62 Cr | 23.20 Cr | 123.11 Cr | 246.10 Cr | 376.53 Cr | 147.72 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2024-12-31 | 0.11 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-09-30 | -0.61 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-06-30 | 0.60 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-03-31 | 0.96 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2023-12-31 | 1.21 Cr | 1.21 Cr | 0.00 Cr | 0.00 Cr | -15.54 Cr | 1.21 Cr | 16.75 Cr | 0.00 Cr | 1.21 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| 2021-11-11 | November 11, 21 | 1219:1000 |
Similar Stocks: Medical - Pharmaceuticals
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| MedPlus Health Services Limited | MEDPLUS | ₹804.05 | ₹96,279,696,851.00 | ₹756,659.00 |
Key Executives
Gender: Not Specified
Year Born:
Gender: male
Year Born: 1941
Gender: male
Year Born:
Gender: male
Year Born:
Gender: Not Specified
Year Born:
Gender: male
Year Born:
Gender: male
Year Born: 1964
Gender: male
Year Born: 1951
Gender: male
Year Born:
FAQs about Natural Capsules Limited
The CEO is Sunil Laxminarayana Kumar Mundra.
The current price is ₹212.95.
The range is ₹163.55-299.
The market capitalization is ₹220.22 crores.
The P/E ratio is 366.47.
The company operates in the Healthcare sector.
Overview of Natural Capsules Limited (ISIN: INE936B01015) is a leading Medical - Pharmaceuticals in India. With a market capitalization of ₹220.22 crores and an average daily volume of 2,746 shares, it operates in the Medical - Pharmaceuticals. The company last declared a dividend of ₹0.